期刊文献+

PEG10基因对FAK介导的肝癌CAM-DR耐药模型中PI3K/Akt通路的影响 被引量:2

Effect of PEG10 gene on FAK mediated PI3K/Akt pathway in human hepatocellular carcinoma CAM-DR resistance
下载PDF
导出
摘要 目的研究化疗药物顺铂(DDP)、5-氟尿嘧啶(5-Fu)、阿霉素(ADM)对PEG10基因稳定表达细胞LO2中FAK介导的肝癌CAM-DR耐药模型中PI3K/Akt通路的影响。方法选择PEG10基因稳定表达LO2细胞株,并构建细胞黏附介导的耐药LO2细胞模型(LO2/CAM-DR细胞),采用不同剂量的顺铂(DDP)、5-氟尿嘧啶(5-Fu)、阿霉素(ADM)作用LO2细胞、LO2/CAM-DR细胞,以及用FAK抑制剂预先干预的LO2/CAM-DR细胞,采用MTT法检测细胞存活率,比较各细胞组中药物的IC50及RI。Western blotting法检测药物作用后细胞中PI3K、AKT、p-AKT蛋白的表达水平;RT-PCR法检测药物处理后细胞中PI3K mRNA水平。结果 LO2细胞、LO2/CAM-DR细胞,以及用FAK抑制剂预先干预的LO2/CAM-DR细胞的存活率均与药物浓度呈负相关,LO2/CAM-DR细胞对药物的敏感性降低,各药作用后IC50均高于LO2细胞,DPP、5-FU和ADM的RI分别为1.345、2.551和2.643。采用FAK抑制剂预先干预的LO2/CAM-DR细胞对药物的敏感性高于LO2/CAM-DR细胞,差异有统计学意义(P<0.05),与LO2细胞相比,差异无统计学意义(P>0.05)。Western blotting检测结果:药物作用后LO2/CAM-DR细胞PI3K、p-AKT的表达水平均高于LO2细胞,差异有统计学意义(P<0.05),采用FAK抑制剂干预后,PI3K、p-AKT的表达水平下降,PI3K mRNA也下降。结论化疗药物与FAK抑制剂的联合使用可以提高化疗药物对肝癌耐药细胞的杀伤作用,下调FAK介导的肝癌CAM-DR耐药模型中PI3K/Akt通路。 Objective To study the effect of chemotherapeutic drug cisplatin ( DDP), 5-fluorouracil (5-Fu) , adria- mycin (ADM) on FAK mediated PI3K/Akt pathway in hepatocellular carcinoma CAM-DR cells model LO2 cell with PEG10 gene stable expression. Methods LO2 cell lines with PEG10 gene stable expression were selected, and the LO2 cell model of adhesion mediated drug resistant (LO2/CAM-DR cells) was constructed, different dose of DDP, 5-Fu, ADM were taken in LO2 cells, LO2/CAM-DR cells, and LO2/CAM-DR cells preintervented with FAK inhibitor, cells survival rate was detected by MTT method, and the cells ICs0 and RI were calculated. The expression levels of PI3K, AKT, p-AKT protein were detected by Western blotting after treated with drugs; PI3K mRNA was detected by RT-PCR after treated with drugs. Results Survival rates of LO2 cells, LO2/CAM-DR cells, and LO2/CAM-DR cells preinter- vented with FAK inhibitor were negative correlation with the drugs concentration, the drug sensitivity of LO2/CAM-DR ceils reduced, IC50 after the drugs effect was higher than that in LO2 ceils, R[ of DPP, 5-FU and ADM were 1. 345, 2.551 and 2. 643. The drug sensitivity of LO2/CAM-DR cells preintervented with FAK inhibitor was higher than that of LO2/CAM-DR cells, and the difference was statistically significant (P 〈 0.05) , compared with LO2 cells, there was no significant difference (P 〉 0.05). Western blotting results showed that the expression levels of PI3K, p-AKT were high- er in LO2/CAM-DR cells than that in LO2 cells, and the difference was statistically significant (P 〈 0.05), but in LO2/ CAM-DR cells preintervented with FAK inhibitor, the expression levels of PI3K, p-AKT were decreased, expression of PI3K mRNA also was decreased. Conclusion Combination chemotherapy and FAK inhibitor can enhance the killing effect of chemotherapy drugs on liver cancer cells, through down regulation of hepatocellular carcinoma CAM-DR resist- ance in Fkt mediated PI3K/Akt pathway.
出处 《胃肠病学和肝病学杂志》 CAS 2015年第5期510-514,共5页 Chinese Journal of Gastroenterology and Hepatology
基金 基因PEG10激活FAK介导的信号通路失调控在肝癌化疗耐药机制中的研究(2013-2014年度湖北省卫生厅科研指导性项目)(JX6C-48)
关键词 FAK CAM-DR耐药模型 PI3K/AKT通路 FAK CAM-DR resistance model PI3K/Akt pathway
  • 相关文献

参考文献10

  • 1王晓嫚,郑哲岚,高枫,袁华琴.甲胎蛋白阴性和阳性原发性肝细胞癌的超声特征比较[J].中国医学影像技术,2014,30(6):877-880. 被引量:7
  • 2林昀,张云丽,胡昕,邓庆,李琦,高勇,滕小梅,韩泽广,黄健.PEG10基因在肝癌组织中高表达的分子机制及其功能的研究[J].肿瘤,2013,33(1):28-35. 被引量:12
  • 3李莹,党国义.血清CEA、CA-199和CA-125检测在原发性肝细胞癌诊断中的临床价值[J].临床和实验医学杂志,2014,13(12):966-968. 被引量:4
  • 4del Carmen MG, Birrer M, Schorge JO. Clear cell carcinoma of the o- vary: a review of the literature [J]. Gynecol Oncol, 2012, 126(3):481-490.
  • 5Wei G, Margolin AA, Haery L, ct al. Chemical genomics identifies small-molecule MCL1 repressors and BCL-xL as a predictor of MCLI dependency [J]. Cancer Cell, 2012, 21 (4): 547-562.
  • 6Inuzuka H, Shaik S, Onoyama I, et al. SCF(FBW7) regulates cellu- lar apoptosis by targeting MCL1 for ubiquitylation and destruction [ J ]. Nature, 2011, 471 (7336) : 104-109.
  • 7Xia H, Nho RS, Kahm J, et al. Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in regulating fibroblast survival in re- sponse to contraction of type I collagen matrices via a beta 1 integrin vi- ability signaling pathway [ J ]. J Biol Chem, 2004, 279 (31 ) : 33024- 33034.
  • 8Zhong X, Rescorla FJ. Cell surface adhesion molecules and adhe- sioninitiated signaling: understanding of anoikis resistance mechanisms and therapeutic opportunities [ J ]. Cell Signal, 2012, 24 ( 2 ) : 393-401,.
  • 9Bouchard V, Harnois C, Demers MJ, et al. Blintegrin/Fak/Src signa- ling in intestinal epithelial erypt cell survival: integration of complex regulatory mechanisms [ J ]. Apoptosis, 2008, 13 (4) : 531-542.
  • 10Brotin E, Meryet-Figuiere M, Simonin K, et al. BeI-XL and MCL-I constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis [ J]. Int J Cancer, 2010, 126(4) : 885-895.

二级参考文献32

  • 1胡迎宾,李定国,陆汉明,吴建新.甲胎蛋白阴性肝癌的临床特点分析[J].实用医学杂志,2006,22(5):550-551. 被引量:7
  • 2黄锦,林菊生,董旭旸,常莹,宋宇虎.PEG10基因siRNA真核表达载体的构建及其对肝癌HepG2细胞凋亡的影响[J].第四军医大学学报,2007,28(3):206-209. 被引量:7
  • 3ONO R, KOBAYASHI S, WAGATSUMA H, etal. A retrotransposon-derived gene, PEGIO, is a novel imprinted gene located on human chromosome 7q21 [J]. Genomics, 2001, 73(2):232-237.
  • 4DONG H, ZHANG H, LIANG J, etal. Digital karyotyping reveals probable target genes at 7q21.3 locus in hepatocellular carcinoma[J]. BMC Med Genomics, 2011,4(111 ):60.
  • 5TSUJI K, YASUI K, GEN Y, et al. PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma[J]. Cancer Genet Cytogenet, 2010, 198(2):118-125.
  • 6HUANG J, SHENG H H, SHEN T, et al. Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma[J]. FEBS lett. 2006. 580(15):3571 -3581.
  • 7HERMAN J G, GRAFF J R, MYOHANEN S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands[J]. Proc Natl AcadSci USA, 1 996, 93(1 8):9821-9826.
  • 8TAKAI D, JONES P A. Comprehensive analysis of CpG islands in human chromosomes 21 and 22[J]. Proc NatlAcad Sci USA, 2002, 99(6):3740-3745.
  • 9(ULIS M, ESTELLER M. DNA methylation and :ancer[J]. Adv Genet, 2010, 70:27-56.
  • 10KALARI S, PFEIFER G P. Identification of driver and passenger DNA methylation in cancer by epigenomic analysis[J]. Adv Genet, 2010, 70:277-308.

共引文献20

同被引文献14

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部